BioAdaptives Inc (BDPT)

[LJ-Bodhi]

The market was not enthused by the 10Q (which came out Monday). Still 25% swings on decent volume though. How long it will last is anyone's guess.

The history of announcing or touting existing products on stock newswire sites is an interesting marketing strategy. It's cheap, for sure. But what's the target audience to actually make sales? Penny traders who want to buy supplements? Explains why revenues are so low.

I'll take a crystal ball stab at the next advertising PR:

The World Health Council predicts arthritis will impact 150m Americans and 1 billion people Worldwide by 2025. Inflammation and mobility problems devastate quality of life. BioAdaptives has developed ArthriPure, a proprietary formulation of recognized herbs, supplements and Chinese medicine known to reduce inflammation and increase mobility. As an added benefit, anecdotal testimonials suggest ArthriPure also aids in growing long, flowing hair similar to a horse's mane. Our wholly owned subsidiary LiveStock is testing ArthriPure on racehorses in a cross-marketing attempt to assist horses with arthritis. Win/Win. By the way, you can buy our stock on the OTC. You can buy ArthriPure at....ummmm....our website?